Evidence ofBCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML)
- 3 March 2020
- journal article
- letter
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 61 (7), 1719-1723
- https://doi.org/10.1080/10428194.2020.1734593
Abstract
(2020). Evidence of BCR-ABL1-positive progenitor spread in blood during molecular recurrence after TKI discontinuation in chronic myeloid leukemia (CML). Leukemia & Lymphoma. Ahead of Print.This publication has 14 references indexed in Scilit:
- Leukemic stem cell persistence in chronic myeloid leukemia patients in deep molecular response induced by tyrosine kinase inhibitors and the impact of therapy discontinuationOncotarget, 2016
- Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable DiseaseJournal of Clinical Oncology, 2014
- BCR-ABL expression in leukemic progenitors and primitive stem cells of patients with chronic myeloid leukemiaBlood, 2012
- Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinibBlood, 2012
- Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatmentBlood, 2011
- Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual diseaseBlood, 2011
- The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescenceLeukemia, 2009
- THEORETICAL STUDY ON ENDOHEDRAL COMPLEXES C2H2–C60, C2H4–C60, AND C2H6–C60Journal of Theoretical and Computational Chemistry, 2008
- CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cellsMolecular Cancer Therapeutics, 2008
- Proliferating status of peripheral blood progenitor cells from patients with BCR/ABL-positive chronic myelogenous leukemiaLeukemia, 2001